Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Stenting ‘an important treatment option’ for PCI patients with complete blockages
The study's lead author emphasized that stenting during CTO PCI procedures "should be considered safe and effective in the long term."
PET imaging reveals long-term heart and lung damage from COVID-19
New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments.
Smaller LV dimensions may increase risk of death for HeartMate 3 LVAD patients
Researchers tracked short- and long-term data from nearly 2,000 patients, presenting their findings in JACC: Heart Failure.
World’s first leadless LBBAP procedures linked to ‘promising’ outcomes
Cardiologists are turning to leadless pacemakers more and more for cardiac pacing, but those devices have not previously been able to perform LBBAP. This new analysis includes new data on the world’s very first leadless LBBAP procedures.
Tirzepatide bests semaglutide in patients with type 2 diabetes, kidney disease and heart failure
Researchers examined data from more than 9,000 patients, sharing their findings at SCAI 2025.

FDA grants fast track designation to Bayer’s new drug for preventing stroke in AFib patients

The new drug, asundexian, is currently the subject of two multicenter Phase III studies—the OCEANIC-AF trial and OCEANIC-STROKE trial—focused on its safety and efficacy.

AFib ablation in young adults linked to improved quality of life, new Cleveland Clinic study confirms

“These and other data support that young adults do as well as a more traditional patient population when looking at arrhythmia-free survival,” researchers wrote.

Mitral Valve Surgery from the University of Washington

Cardiologists make history, removing device and implanting new valve in first heart procedure of its kind

“I was ready to make out my will, so this came along just at the right time,” the 76-year-old patient said.

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

TVT 2023: Cardiovascular Research Foundation announces late-breaking clinical trials

In addition to these 15 late-breaking clinical studies, TVT 2023 will feature live cases, hands-on training, poster presentations and much more.

Data on a next-generation balloon-expandable transcatheter heart valve

Next-gen TAVR valve, tested on patients for very first time, linked to high success rate

A new-look TAVR valve was tested on patients for the first time, leading researchers to say its use appears to be "feasible and safe." More research, of course, is still required.

old elderly couple coffee drink retired love romance man

New data suggest that the burden of atherosclerosis on imaging might not be as indicative of major cardiovascular events as a person’s age and sex.

Links to all the late-breaking trials for Heart Rhythm 2023

Heart Rhythm 2023, the society's 44th annual meeting, is scheduled for May 19-21.

M&A mergers and acquisitions business deal

Report: Medtronic, Johnson & Johnson consider Shockwave Medical acquisition after Boston Scientific talks stall

Shockwave Medical has already had a busy, successful 2023—what could be next for the IVL specialists?

Clinical

Stenting ‘an important treatment option’ for PCI patients with complete blockages

PET imaging reveals long-term heart and lung damage from COVID-19

Smaller LV dimensions may increase risk of death for HeartMate 3 LVAD patients

World’s first leadless LBBAP procedures linked to ‘promising’ outcomes

Tirzepatide bests semaglutide in patients with type 2 diabetes, kidney disease and heart failure